We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...
Swiss National Bank boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 188,400 ...
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...
10x Genomics (NASDAQ:TXG) reported Q1 EPS of ($0.38), $0.07 worse than the analyst estimate of ($0.31). Revenue for the quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results